Image of Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy

LITERATURE

Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy


Hyperammonemia and associated cerebral edema cause neurological abnormalities in liver disease patients.
Although only 15% of ammonia production originates in the colon, management strategies for hepatic encephalopathy (HE) have focused on reducing ammonia generation from the bowel rather than on manipulating systemic mechanisms involved in ammonia metabolism. administration of L-ornithine L-aspartate (LOLA) improves
mental status and decreases serum and spinal fluid ammonia levels by stimulating both the urea
cycle and glutamine (Gln) synthesis, which are key metabolic pathways in ammonia detoxification.


Availability

Lolindex-001Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Annals of Hepatology 2011; 10 (Suppl.2): S55-S59
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous